...London School of Engineering and Materials Science Laboratory report writing instructions DEN101 - Fluid Mechanics 1 Flow Rate Measurement Experiment A. Student Student Number: 1234567 Version 2.0, 27 November 2010 Template for Word 97-2003 Abstract This document explains what is expected in your Fluids 1 lab report. The sections that should be covered are outlined and a structure you could follow is proposed. Detailed advice on how to edit the report is given. The document concludes with the marking criteria for this lab report. Table of Contents Abstract 2 1. Introduction 3 1.1. Writing 3 1.2. Editing and formatting 3 1.3. Content of the introduction 4 2. Background and theory 4 3. Apparatus 4 4. Test 4 5. Experimental procedure 4 6. Results 5 7. Discussion 5 8. Conclusions 5 9. References 5 10. Appendix A: Marking criteria 6 Introduction Before starting to write a report, you should think about what is your audience. Am I writing for colleagues who want a lot of detail how it is done, or am I writing for my boss who just wants an executive summary as he has no time for details? In general, there is not a single type of audience and we have to make our writing suitable for the detailed read, as well as the fast perusal. To understand what is required from you in this report, please have a look at the marking criteria in the Appendix. 1 Writing To limit...
Words: 2017 - Pages: 9
...BACTERIA AND ANTIBIOTICS LAB REPORT Bryan Bennett Ms. Johnson Biology 09 period 8 March 12, 2013 Introduction: 1. Eubacteria -Has cell wall with peptidoglycan -They can live nearly anywhere on earth (sky to underground) -Unicellular -Prokaryotic -Reproduce Asexually Archaebacteria -Cell wall without peptidoglycan -Live in environments without oxygen (anaerobic) -Prokaryotic -Unicellular -Reproduce Asexually -Oldest bacterial form -Unique lipids in their cell membrane -DNA sequence is more like other Eukaryotes than other bacterial types (eubacteria) 2. Bacteria are classified into four groups: * PHOTOAUTOTROPHS * PHOTOHETEROTROPHS * CHEMOAUTOTROPHS * CHEMOHETEROTROPHS 3. 4. Many bacteria are heterotrophic which is to thrive off other organisms. The type of bacteria that causes disease are heterotrophic parasites. There are also many harmless bacterial parasites, many of which can be helpful to their hosts. Autotrophic bacteria manufacture their own food by chemosynthesis and photosynthesis. In aerobic respiration a series of reactions convert glucose to carbon dioxide and water and give off energy. Free oxygen is required as the final acceptor for electrons and hydrogen to form water. Bacteria, able to grow in the presence of oxygen, are called aerobic bacteria. Pseudomonas is an example of aerobic bacteria. In anaerobic respiration free oxygen isn’t required. Organic compounds are the final electron acceptors in anaerobic...
Words: 1569 - Pages: 7
...------------------------------------------------- Antimicrobial Susceptibility, MIC and MBC ------------------------------------------------- Microbiology Lab Report 3 Carolina Toscanojara Antibiotic Sensitivity. Objective: Antibiotics are chemical compounds that selectively interfere with the growth of microorganisms while causing little or no damage to the animal or human host. The purpose of this lab was to determine the effectiveness antibiotics against any given bacterium by means of examining the zone of inhibition, the minimum inhibitory concentration, and the minimum bactericidal concentration. Introduction: Chemical antimicrobial agents are chemical compounds that are capable of either preventing the microorganisms for multiplying (bacteriostatic) in order for the immune system of the host to overcome them or killing them completely (bactericidal). Antibiotics taken to improve the symptoms from a disease are called chemotherapeutic drugs; they are produced by a microorganism such as bacterium or fungus and/or are derived from a chemical produced by one. The test carried out to determine which antibiotic will be most successful in treating certain bacteria is called Antibiotic Susceptibility Test (AST) and it is often done by the Kirby-Bauer method, which uses Muller Hinton agar and paper discs containing specific concentrations of antibiotics are placed on the agar surface after rubbed with bacterial specimen. Results of AST are examined for zones of inhibition...
Words: 2208 - Pages: 9
...treatment so one of the samples in the study is untreated, and should contain a greater amount of antibiotic resistant bacteria and the sample that is further along in treatment phase should contain a smaller number of antibiotic resistant samples. The study should demonstrate that, as the wastewater moves through the stages of treatment, less antibiotic resistant bacteria should be detected. The samples should demonstrate that even with treatment, there are still antibiotic resistant bacteria present. Two samples were collected from a local Wastewater Treatment Plant and were taken back to the lab where further study could be done on the types of bacteria that were present. The samples were taken at different stages of treatment. The purpose of this study was to determine what, if any types of antibiotic resistant bacteria were present in the wastewater. The samples taken were processed in the lab, and then agar plated to produce colonies. The colonies were separated using the quadrant streak method to grow individual colonies. These individual colonies were sampled with inoculating needles to determine if there were any single bacterial colony present that was antibiotic resistant. The concentration of ARB was way greater in the semi-treated wastewater than in the untreated wastewater. 86% were resistant to ampicillin in the untreated and 63% in the semi-treated this showed that there was only a 23% reduction. There was only a 26% out of 50% reduction in erythromycin, 13% out of 44%...
Words: 1995 - Pages: 8
...Streptococcus pneumoniae. The means of transmission of Streptococcus pneumoniae is via respiratory droplet from the mouth or nose of an infected person or a carrier. Penicillin became available in the 1940’s which changed radically the treatment of pneumococcal pneumonia which was based on watchful waiting. Despite this major development pneumonia still posed a major clinical problem today because of the resistance the organism developed against anti -microbial agents.Penicillin resistance is caused by a mosaic mutation of penicillin binding Protein (PBP) genes due to interspecies recombination of homologous genes. It is also recognized that a penicillin resistant pneumococcal in most cases is resistant to other antibiotics such as macrolide, tetracycline, co-trimoxazole, chloramphenicol and clindamycin.Antimicrobial resistance have limit the choice of treatment for many pneumonococcal diseased because of resistance these organism have built up against a number of antibiotice.For instance penicillin is said to be resistant to a list of...
Words: 3244 - Pages: 13
...rich tradition for the treatment of these infectious diseases (Titilope et al., 2012), both infectious and non-infectious. Attah et al. (2012) makes similar claims with the evaluation and development of compounds from similar claims with the evaluation and development of compounds from medicinal plants for the treatment of diseases which is one of the areas that is gaining grounds and acceptability world-wide (p.1). According to the World Health Organization, medicinal plants would be the best source to acquire different effective drugs and, therefore, those plants should undergo investigation to have a better understanding of their properties, safety and efficacy (Rajeh et al., 2010; Nascimiento et al., 2000). There are some published reports describing the antimicrobial activity of various crude plant extracts (Igoli et al., 2005; Alzoreky et al., 2003). It is estimated that there are about 2.5 million species of higher plants and the majority of these have not yet been examined for their pharmacological activities (Ram et al., 2003). In relation with the applications of herbal plants, weed, which is a plant that grows out of place and is competitive, persistent and pernicious (James et al., 1991), have been a part of civilization and many ancient documents speak of humans battling weeds in the crops they grow and also found to be resistant to most of the microbial disease that made us interested to know the potency behind (Ibrahim et al., 2012). Furthermore, according to...
Words: 3671 - Pages: 15
...MicroBiology- MLT1 LabPaq / Published by: Hands-On Labs, Inc. sales@labpaq.com / www.LabPaq.com / Toll Free 866.206.0773 A Laboratory Manual of Small-Scale Experiments for the Independent Study of Microbiology 50-0222-MB-01 LabPaq® is a registered trademark of Hands-On Labs, Inc. (HOL). The LabPaq referenced in this manual is produced by Hands-On Labs, Inc. which holds and reserves all copyrights on the intellectual properties associated with the LabPaq’s unique design, assembly, and learning experiences. The laboratory manual included with a LabPaq is intended for the sole use by that LabPaq’s original purchaser and may not be reused without a LabPaq or by others without the specific written consent of HOL. No portion of any LabPaq manual’s materials may be reproduced, transmitted or distributed to others in any manner, nor may be downloaded to any public or privately shared systems or servers without the express written consent of HOL. No changes may be made in any LabPaq materials without the express written consent of HOL. HOL has invested years of research and development into these materials, reserves all rights related to them, and retains the right to impose substantial penalties for any misuse. Published by: Hands-On Labs, Inc. 3880 S. Windermere St. Englewood, CO 80110 Phone: Denver Area: 303-679-6252 Toll-free, Long-distance: 866-206-0773 www.LabPaq.com E-mail: info@LabPaq.com Printed...
Words: 31695 - Pages: 127
...Overview of Bioterrorism This course has been awarded two (2.0) contact hours. This course expires on November 12, 2014. Copyright © 2008 by RN.com. All Rights Reserved. Reproduction and distribution of these materials are prohibited without the express written authorization of RN.com. First Published: Updated: November 12, 2008 Nov 12, 2011 IMPORTANT INFORMATION RN.com strives to keeps its content fair and unbiased. The author has no conflicts of interest to disclose. The planners of the educational activity have no conflicts of interest to disclose. (Conflict of Interest Definition: Circumstances create a conflict of interest when an individual has an opportunity to affect Education content about products or services of a commercial interest with which he/she has a financial relationship.) There is no commercial support being used for this course. Participants are advised that the accredited status of RN.com does not imply endorsement by the provider or ANCC of any products/therapeutics mentioned in this course. The information in the course is for educational purposes only. There is no “off label” usage of drugs or products discussed in this course. Acknowledgements RN.com acknowledges the valuable contributions of… Material protected by Copyright …The Centers for Disease Control (CDC) (www.cdc.gov), the key government agency responsible for disseminating knowledge about various biological agents. …U.S. Medical Research Institute of Infectious Diseases...
Words: 6008 - Pages: 25
...Dear nutrition student, Thank you for inquiring about my RD/DTR study guide. And yes, there is no catch, the study guide is COMPLETELY FREE! All I ask for is some feedback. So feel free to shoot me any questions/comments! A little background: This study guide is the culmination of years of my own research. And after careful thought, I put into the study guide what I feel are the most important concepts you need to know for the RD/DTR exam. If you notice, I spent much time teaching you in detail the concepts you need to know, not just “spitting” you questions with little or no explanation. I believe this is important. I know you might be thinking “oh, how am I going to absorb and learn all this material?” I say, just read and answer the questions at your own pace. Simply test yourself and of course take some breaks along the way. Just take it one concept at a time. After you have mastered one concept, then move on to the next. I know if you study whole-heartedly what I have outlined in this study guide, you are sure to pass! GOOD LUCK! YOU CAN DO IT! ϑ Your nutrition friend, -Jonathan Brown, B.S, DTR THE “NO FLUFF” RD/DTR STUDY GUIDE *Updated as of July 2011 The “NO FLUFF” RD/DTR STUDY GUIDE Tips for taking the RD/DTR exam 1. PERIODICALLY CHECK THE CLOCK TO MAKE SURE YOU’RE GOOD ON TIME! If you wish, get a basic digital watch with a timer for...
Words: 20721 - Pages: 83
...well managed with enalapril (Vasotec) past six years, diagnosis (Dx) of pneumonia yearly for the past three years. D.Z. appears cachectic with difficulty breathing at rest. Patient reports productive cough with thick yellow-green sputum. He seems anxious and irritable during subjective data collection. He states, he has been a 2-pack-a-day smoker for 38 years. He complains of (c/o) insomnia and tiredness. His vital signs (VS) are 162/84, 124, 36, 102° F, SaO2 88%. Admitting diagnosis is chronic emphysema with acute exacerbation. Admitting orders includes: diet as tolerated; out of bed with assistance; oxygen (O2) to maintain SaO2 of 90%; maintenance IV of D5W at 50 ml/hr.; intake and output (I&O); arterial blood gases (ABGs) in AM; CBC with differential, basic metabolic panel (BMP), and theophylline (Theo-Dur) level on admission; chest x-ray (CXR) q24h; prednisone 60 mg/day PO; doxycycline 100 mg PO q12h x10 days, azithromycin 500 mg IV piggyback (IVPB) q24h x2 days then 500 mg PO x 7 days; theophylline 300 mg PO bid; heparin 5000 units SC q12h; albuterol 2.5 mg (0.5 ml) in 3 ml normal saline (NS) and ipratropium 500 mg by nebulizer q4-6h; enalapril 10 mg PO q AM. In this case, I will discuss the definition of COPD/emphysema, causes, S/S, risk factors, contributing factors, normal lab values, current lab values, diagnostic tests, prevention, treatment, patient care, education, and discharge instructions. Chronic Obstructive Pulmonary Disease (COPD); Emphysema Patient D.Z...
Words: 6939 - Pages: 28
...Natural product From Wikipedia, the free encyclopedia Jump to: navigation, search | This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (January 2009) | Paclitaxel (Taxol) is a natural product derived from the Yew tree.[1] A natural product is a chemical compound or substance produced by a living organism - found in nature that usually has a pharmacological or biological activity for use in pharmaceutical drug discovery and drug design. A natural product can be considered as such even if it can be prepared by total synthesis. These small molecules provide the source or inspiration for the majority of FDA-approved agents and continue to be one of the major sources of inspiration for drug discovery. In particular, these compounds are important in the treatment of life-threatening conditions.[2] Contents[hide] * 1 Natural sources * 2 Screening of natural products * 2.1 The plant kingdom * 2.2 The microbial world * 2.3 The marine world * 2.4 Animal sources * 2.5 Venoms and toxins * 3 Traditional Medicine * 4 Isolation and purification * 5 Synthesis * 6 See also * 7 References * 8 External links * 9 Further reading | [edit] Natural sources Natural products may be extracted from tissues of terrestrial plants, marine organisms or microorganism fermentation broths. A crude (untreated) extract from any one of...
Words: 3118 - Pages: 13
...Red de Revistas Científicas de América Latina, el Caribe, España y Portugal Sistema de Información Científica Duangporn Kantachote, Pakorn Prachyakij, Wilawan Charernjiratrakul, Metta Ongsakul, Yodsawee Duangjitcharoen, Chaiyavat Chaiyasut, Teruhiko Nitoda, Hiroshi Kanzaki Characterization of the antiyeast compound and probiotic properties of a starter Lactobacillus plantarum DW3 for possible use in fermented plant beverages Electronic Journal of Biotechnology, vol. 13, núm. 5, 2010, pp. 1-15, Pontificia Universidad Católica de Valparaíso Chile Available in: http://www.redalyc.org/articulo.oa?id=173318799002 Electronic Journal of Biotechnology, ISSN (Electronic Version): 0717-3458 edbiotec@ucv.cl Pontificia Universidad Católica de Valparaíso Chile How to cite Complete issue More information about this article Journal's homepage www.redalyc.org Non-Profit Academic Project, developed under the Open Acces Initiative Electronic Journal of Biotechnology ISSN: 0717-3458 http://www.ejbiotechnology.info DOI: 10.2225/vol13-issue5-fulltext-1 Characterization of the antiyeast compound and probiotic properties of a starter Lactobacillus plantarum DW3 for possible use in fermented plant beverages Duangporn Kantachote1 1 · Pakorn Prachyakij1 · Wilawan Charernjiratrakul1 Metta Ongsakul · Yodsawee Duangjitcharoen2 · Chaiyavat Chaiyasut2 Teruhiko Nitoda3 · Hiroshi Kanzaki3 1 Department of Microbiology, Faculty of Science, Prince of Songkla University,...
Words: 7395 - Pages: 30
...0 3 0 Electronic Health Records in the Physician Office CHAPTER OUTLINE Patient Flow in the Physician Practice Step 1. Pre-Visit: Appointment Scheduling and Information Collection Step 2. Patient Check-in and Payment Collection Step 3. Rooming and Measuring Vital Signs Patient Examination and Documentation Step 4. Patient Checkout Step 5. Post-Visit: Coding and Billing Post-Visit: Reviewing Test Results Coding and Reimbursement in Electronic Health Records Computer-Assisted Coding Clinical Tools in the Electronic Health Record Decision-Support Tools Tracking and Monitoring Patient Care Screening for Illness or Disease Identifying at-Risk Patients Managing Patients with Chronic Diseases Improving the Quality and Safety of Patient Care with Evidence-Based Guidelines E-Prescribing and Electronic Health Records Keeping Current with Electronic Drug Databases Increasing Prescription Safety Saving Time and Money LEARNING OUTCOMES After completing this chapter, you will be able to define key terms and: 1. 2. 3. 4. 5. 6. 7. 8. 9. List the five steps of the office visit workflow in a physician office. Discuss the advantages of pre-visit scheduling and information collection for patients and office staff. Describe the process of electronic check-in. Explain how electronic health records make documenting patient exams more efficient. Explain what occurs during patient checkout. Explain what two events take place during the post-visit step of the visit workflow. Describe the advantages of computer-assisted...
Words: 12974 - Pages: 52
...0 3 0 Electronic Health Records in the Physician Office CHAPTER OUTLINE Patient Flow in the Physician Practice Step 1. Pre-Visit: Appointment Scheduling and Information Collection Step 2. Patient Check-in and Payment Collection Step 3. Rooming and Measuring Vital Signs Patient Examination and Documentation Step 4. Patient Checkout Step 5. Post-Visit: Coding and Billing Post-Visit: Reviewing Test Results Coding and Reimbursement in Electronic Health Records Computer-Assisted Coding Clinical Tools in the Electronic Health Record Decision-Support Tools Tracking and Monitoring Patient Care Screening for Illness or Disease Identifying at-Risk Patients Managing Patients with Chronic Diseases Improving the Quality and Safety of Patient Care with Evidence-Based Guidelines E-Prescribing and Electronic Health Records Keeping Current with Electronic Drug Databases Increasing Prescription Safety Saving Time and Money LEARNING OUTCOMES After completing this chapter, you will be able to define key terms and: 1. 2. 3. 4. 5. 6. 7. 8. 9. List the five steps of the office visit workflow in a physician office. Discuss the advantages of pre-visit scheduling and information collection for patients and office staff. Describe the process of electronic check-in. Explain how electronic health records make documenting patient exams more efficient. Explain what occurs during patient checkout. Explain what two events take place during the post-visit step of the...
Words: 12974 - Pages: 52
...| VET223: Animal Diseases, Pathology and Immunology Research Project | Cassandra Reid | | | | Student number; 21611523 | December 4, 2013 | | Dirofilaria immitis Dirofilaria immitis otherwise known as canine heartworm disease. It is a parasitic worm that lives as an adult in the right side of the animal’s heart, and large blood vessels leading to the lungs. The mosquitoes are the intermediate host for heartworms. The female adult worms in the heart and vessels microfilariae in the blood, which are immature worms that can live up to three years. The mosquitos feeds on animals and ingest the microfilaria which matures in the mosquito for about two weeks to become an infected larva. When the mosquito feeds on another animal the microfilariae is passed to that animal. There the microfilariae the larva develops over three to six months, and migrate to the right side of the heart. About six months the larva develops into an adult worm. The adult worm can live up to seven years, and produce microfilaria which completes the life cycle. Heart worms a very serious health issue. Which can lead to right ventricular dilation, hypertrophy, heart failure, and death. Clinical signs can occur within six months or latter from the time on infected. The physical signs can be very mild to severe depending on the number of adult worms present. Which can range from coughing, difficulty breathing, and abnormal heart sounds to death. There are several tests that...
Words: 7185 - Pages: 29
